EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.21.117 | Adenocarcinoma |
15492784 |
Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 3.4.21.117 | Adenocarcinoma |
17354228 |
Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
3
0 |
| 3.4.21.117 | Adenocarcinoma |
18343220 |
The extracellular matrix protein fibronectin is a substrate for kallikrein 7. |
causal interaction
diagnostic usage
unassigned |
2
2
0 |
| 3.4.21.117 | Adenocarcinoma |
22573795 |
Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 3.4.21.117 | Alzheimer Disease |
14972646 |
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 3.4.21.117 | Alzheimer Disease |
29311134 |
Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice. |
causal interaction
ongoing research
unassigned |
1
3
0 |
| 3.4.21.117 | Breast Neoplasms |
14691584 |
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
1 |
| 3.4.21.117 | Breast Neoplasms |
16627559 |
Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer. |
diagnostic usage
ongoing research
unassigned |
4
3
0 |
| 3.4.21.117 | Breast Neoplasms |
18976018 |
Expression of the serine protease kallikrein 7 and its inhibitor antileukoprotease is decreased in prostate cancer. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 3.4.21.117 | Breast Neoplasms |
21868565 |
Evaluation of Kallikrein-related Peptidase 5 Expression and its Significance for Breast Cancer Patients: Association with Kallikrein-related Peptidase 7 Expression. |
diagnostic usage
unassigned |
3
0 |
